Interviews

Range Biotechnologies is a company developing next gen diagnostics for the next stage of human health. Pulse 2.0 interviewed Range Biotechnologies co-founder and CEO Brandon Wilson, Ph.D., to learn more.

Longevity.Technology: Proteomics, the study of proteins in the body, has long been touted for its potential to help develop more effective ways to diagnose, treat and prevent diseases, but the field to date has largely focused on the discovery of protein biomarkers. Range Bio is founded on the belief that a significant impact on human health can only be realized if biomarker discovery is complemented by scalable, targeted quantification of proteins. We caught up with the company’s CEO Dr Brandon Wilson and CTO Dr Nicolo Maganzini to find out more.